Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Article
[키워드] acute respiratory syndrome
administration
affecting
Analysis
analysis
anti-RBD IgG antibody
anti-SARS-CoV-2
AUC
automated
binding antibody
booster
clinical settings
Cohort
collected
Control
coronavirus
correlation
COVID-19
cutoff value
demonstrated
Effectiveness
Genscript
gold standard
Immunity
immunoassay
in both groups
infected patient
Mindray
NAb
neutralization
Neutralization assay
neutralization test
neutralizing antibody
population level
protective immunity
provide
pseudovirus
R 2
Rapid
receiver operating characteristic
Research
ROC
ROC Curve
Sample
SARS-CoV-2
SARS-CoV-2 infected patient
second dose
sensitivity
shown
significantly
specificity
subjects
sVNT
sVNT assay
symptoms onset
tested
threshold
vaccinated individual
Vaccine
virus neutralization test
was performed
[DOI] 10.1038/s41598-022-21317-x PMC 바로가기
[DOI] 10.1038/s41598-022-21317-x PMC 바로가기